These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22675171)

  • 41. Genetically heterogeneous glioblastoma recurring with disappearance of 1p/19q losses: case report.
    Ito M; Wakabayashi T; Natsume A; Hatano H; Fujii M; Yoshida J
    Neurosurgery; 2007 Jul; 61(1):E168-9; discussion E169. PubMed ID: 17621007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation.
    Jin X; Jeon HY; Joo KM; Kim JK; Jin J; Kim SH; Kang BG; Beck S; Lee SJ; Kim JK; Park AK; Park WY; Choi YJ; Nam DH; Kim H
    Cancer Res; 2011 Apr; 71(8):3066-75. PubMed ID: 21363911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas.
    Pareira ES; Shibuya M; Ohara K; Nakagawa Y; Kanazawa T; Kamamoto D; Kato Y; Arai E; Aimono E; Yoshida K; Nishihara H; Kanai Y; Sasaki H
    Brain Tumor Pathol; 2022 Apr; 39(2):79-87. PubMed ID: 35292862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetics and imaging of oligodendroglial tumors.
    Ellenbogen JR; Walker C; Jenkinson MD
    CNS Oncol; 2015; 4(5):307-15. PubMed ID: 26478219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glioma-propagating cells as an in vitro screening platform: PLK1 as a case study.
    Foong CS; Sandanaraj E; Brooks HB; Campbell RM; Ang BT; Chong YK; Tang C
    J Biomol Screen; 2012 Oct; 17(9):1136-50. PubMed ID: 22927677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
    Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
    Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chromosomal imbalances in primary oligodendroglial tumors and their recurrences: clues about malignant progression detected using comparative genomic hybridization.
    Jeuken JW; Sprenger SH; Vermeer H; Kappelle AC; Boerman RH; Wesseling P
    J Neurosurg; 2002 Mar; 96(3):559-64. PubMed ID: 11892633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Molecular biology of oligodendroglial tumors].
    Laigle-Donadey F; Benouaich-Amiel A; Hoang-Xuan K; Sanson M
    Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):260-8. PubMed ID: 16292170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sarcoma-like tumor originating from oligodendroglioma.
    Shoji T; Saito R; Kanamori M; Sonoda Y; Watanabe M; Tominaga T
    Brain Tumor Pathol; 2016 Oct; 33(4):255-260. PubMed ID: 27333891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas.
    Liu Y; Hu H; Zhang C; Wang H; Zhang W; Wang Z; Li M; Zhang W; Zhou D; Jiang T
    Oncotarget; 2015 Nov; 6(35):38257-69. PubMed ID: 26468983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oligodendroglial tumors: diagnostic and molecular pathology.
    Rodriguez FJ; Giannini C
    Semin Diagn Pathol; 2010 May; 27(2):136-45. PubMed ID: 20860317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular pathology of malignant gliomas.
    Louis DN
    Annu Rev Pathol; 2006; 1():97-117. PubMed ID: 18039109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative analysis of histologically classified oligodendrogliomas reveals characteristic molecular differences between subgroups.
    Lauber C; Klink B; Seifert M
    BMC Cancer; 2018 Apr; 18(1):399. PubMed ID: 29631562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glioblastoma with oligodendroglial components: glioblastoma or anaplastic oligodendroglial tumors.
    Takeuchi H; Hosoda T; Kitai R; Kodera T; Arishima H; Tsunetoshi K; Neishi H; Yamauchi T; Sato K; Imamura Y; Itoh H; Kubota T; Kikuta K
    Brain Tumor Pathol; 2012 Jul; 29(3):154-9. PubMed ID: 22527749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
    Kristoffersen K; Nedergaard MK; Villingshøj M; Borup R; Broholm H; Kjær A; Poulsen HS; Stockhausen MT
    Cancer Biol Ther; 2014 Jul; 15(7):862-77. PubMed ID: 24755988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
    Saito N; Fu J; Zheng S; Yao J; Wang S; Liu DD; Yuan Y; Sulman EP; Lang FF; Colman H; Verhaak RG; Yung WK; Koul D
    Stem Cells; 2014 Jan; 32(1):301-12. PubMed ID: 24038660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A combined gene signature of hypoxia and notch pathway in human glioblastoma and its prognostic relevance.
    Irshad K; Mohapatra SK; Srivastava C; Garg H; Mishra S; Dikshit B; Sarkar C; Gupta D; Chandra PS; Chattopadhyay P; Sinha S; Chosdol K
    PLoS One; 2015; 10(3):e0118201. PubMed ID: 25734817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells.
    Sarkar S; Mirzaei R; Zemp FJ; Wei W; Senger DL; Robbins SM; Yong VW
    Cancer Res; 2017 Jun; 77(12):3231-3243. PubMed ID: 28416488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Genetics and brain gliomas].
    Alentorn A; Labussière M; Sanson M; Delattre JY; Hoang-Xuan K; Idbaih A
    Presse Med; 2013 May; 42(5):806-13. PubMed ID: 22789312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications.
    Perry A; Scheithauer BW; Macaulay RJ; Raffel C; Roth KA; Kros JM
    J Neuropathol Exp Neurol; 2002 Nov; 61(11):947-55. PubMed ID: 12430711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.